IMMUNE CHECKPOINT INHIBITORS
Clinical Manifestation and Management of Immune Checkpoint Inhibitor–Associated Cardiotoxicity
In this review, authors identify and characterize immune checkpoint inhibitor–associated cardiotoxicity and summarize diagnosis and treatment strategies. Although it is listed as a clinical guideline, the article does not follow strict rules for the development of guidelines.
Thoracic CancerMeet the Faculty
Videos
-
Immune Checkpoint Inhibitors Managing Cardiotoxicity Associated With Immune Checkpoint Inhibitor Therapy
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: Incidence and Patient Risk Factors
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: The Pharmacist Perspective
